Akt expression and compartmentalization in prediction of clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab

Trastuzumab is effective in about half of HER2-positive breast cancer patients. The PI3K/Akt signalling pathway plays an important role in the process of primary and secondary resistance to anti-HER2 targeted therapy. We evaluated the relationship between expression, activation and subcellular local...

Descripción completa

Detalles Bibliográficos
Autores principales: GRELL, PETER, FABIAN, PAVEL, KHOYLOU, MARTA, RADOVA, LENKA, SLABY, ONDREJ, HRSTKA, ROMAN, VYZULA, ROSTISLAV, HAJDUCH, MARIAN, SVOBODA, MAREK
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2012
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583615/
https://www.ncbi.nlm.nih.gov/pubmed/22842582
http://dx.doi.org/10.3892/ijo.2012.1576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583615/
https://www.ncbi.nlm.nih.gov/pubmed/22842582
http://dx.doi.org/10.3892/ijo.2012.1576

Ejemplares similares